News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
An action plan to tackle critical gaps in breast cancer research
Research facilitated by Breast Cancer Campaign has identified the ten critical gaps that exist in breast cancer research.
Radiotherapy could spare bladder cancer patients surgery
Radiotherapy is an effective treatment for aggressive bladder cancer and could improve quality of life by sparing patients surgery, according to an ICR study.
Ultrasound: more than just baby pictures
For many people, the word ‘ultrasound’ conjures up images of nurses and doctors showing grainy footage of foetuses to pregnant women. Although imaging unborn babies is undoubtedly important, the technology has an incredible array of clinical uses outside the obstetrician’s office.
Innovative MRI scan monitors cancer gene therapy
A new type of MRI scan could be used to monitor the effectiveness of an innovative new gene therapy for cancer, say scientists from The Institute of Cancer Research, London.
Study of 'sister' stem cells uncovers new cancer clue
Using a new technique for examining stem cells, ICR scientists uncover dramatic differences in the gene expression levels between identical 'sister' pairs.
BACIT Limited makes first investment in ICR drug development programme
BACIT Limited, an innovative investment company with a financial model designed to help fund the battle against cancer has invested in its first drug development project
Less is more for radiotherapy in early breast cancers
Less is more for radiotherapy in early breast cancers
The Wellcome Trust award £4 million to the ICR
The Institute of Cancer Research, London, has been awarded £4 million from the Wellcome Trust to continue their groundbreaking work developing cancer drugs that inhibit the PARP enzyme tankyrase.
Statement in reaction to the Science and Technology Committee report on clinical trials
The ICR support wider registration and reporting of clinical trials, but explain that a more pressing issue is the burden of EU regulation which is holding up clinical trials to find better cancer treatments.
New research turns cancer’s own weapons against itself
Scientists have discovered a potential new way of treating a type of blood cancer called myeloma that poisons cancer cells with their own secretions.
Advanced scan looks inside tumours to tell if cancer cells have died
A high-tech imaging technique can allow scientists to see into the middle of tumours and tell whether treatments are killing the cancer cells inside, new research reports.
Collagen clue reveals new drug target for untreatable form of lung cancer
Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new ICR study reveals.
